Epstein Secrets

From: James Meiskin < To: Lesley Groff Subject: Re: Confidential Date: Wed, 02 Jul 2014 14:07:41 +0000 Thank you. James Sent from my iPhone On Jul 1, 2014, at 7:3

logies that are worthy of development. RVC has already agreed to finance the first (MAR) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capit

From: James Meiskin To: Lesley Groff c; Subject: Re: Confidential Date: Thu, 29 May 2014 14:04:49 +0000 Hope we can reschedule. Thank you. James Sent from my iPho

ogies that are worthy of development. RVC has already agreed to finance the first (MALI) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capit

stein cti Subject: Fwd: Confidential Date: Wed, 21 May 2014 13:28:20 +0000 Attachments: DaCart_Presentation.pptx Begin forwarded message: From: "James Meiskin" < Subject: FW: Confidential Date: Ma 21, 2014 9:23:58 AM EDT To: Reply-To: Jeffrey, David Carter (Company information is attached), is in NY to

logies that are worthy of development. RVC has already agreed to finance the first (MALI) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capit

ot in ny until June but happy to see you both after Might it be possible to schedule something the beginning of June? On May 21, 2014, at 9:23 AM, "James Meiskin" •c:a wrote: Jeffrey, David Carter (Company information is attached), is in NY today and tomorrow morning, and I felt that it could be beneficial

ologies that are worthy of development. RVC has already agreed to finance the first (MAR) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capit

Re: Confidential Date: Wed, 21 May 2014 13:28:35 +0000 Thanks James...I will forward to Jeffrey...hope you are well. On May 21, 2014, at 9:23 AM, "James Meiskin" • wrote: Jeffrey, David Carter (Company information is attached), is in NY today and tomorrow morning, and I felt that it could be beneficial and

logies that are worthy of development. RVC has already agreed to finance the first (MALI) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capit

ning James...I don't think Jeffrey will be back in NY this month but one never knows! Let me give him your new dates... On Dec 8, 2014, at 7:26 AM, James Meiskin < wrote: Anytime between the 15th - 171h of this month would be great. Thank you, James From: [mailto: Sent Wednesday, December 03, 2014 7:39 A

ologies that are worthy of development. RVC has already agreed to finance the first (MAR) and is looking at the next two—Prediction Biosciences, and OvationBio. I EFTA00357058 have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a

t 2014 13:38:40 +0000 Great! thanks James...I will pass this along and hopefully Jeffrey will be available. Thank you, On Oct 29, 2014, at 8:15 AM, James Meiskin < wrote: I attached the updated deck for JE's review. David Carter would like to meet Jeffrey over the next several weeks if possible, and I think

logies that are worthy of development. RVC has already agreed to finance the first (MAJI) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capit

arch 05, 2015 11:09 AM To: ben carter Subject: Investment Opportunities Dear Lesley, Here is my email for Jeffery. Thanks, David Dear Jeffery, James Meiskin suggested you might have an interest in what I am doing. Since you offered to look at what I am up to, I have attached the full story. It is essenti

ly. It will be a challenge to find investors, sensitive to risk and return, to provide OvationBio the capital it needs to do its early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the bigges

arch 05, 2015 11:09 AM To: ben carter Subject: Investment Opportunities Dear Lesley, Here is my email for Jeffery. Thanks, David Dear Jeffery, James Meiskin suggested you might have an interest in what I am doing. Since you offered to look at what I am up to, I have attached the full story. It is essenti

ly. It will be a challenge to find investors, sensitive to risk and return, to provide OvationBio the capital it needs to do its early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the bigges

arch 05, 2015 11:09 AM To: ben carter Subject: Investment Opportunities Dear Lesley, Here is my email for Jeffery. Thanks, David Dear Jeffery, James Meiskin suggested you might have an interest in what I am doing. Since you offered to look at what I am up to, I have attached the full story. It is essenti

ly. It will be a challenge to find investors, sensitive to risk and return, to provide OvationBio the capital it needs to do its early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the bigges